What Happened?
Laval, PQ-based ProMetic Appointed Pierre Laurin as Chief Executive Officer
About the Company
ProMetic Life Sciences Inc. (www.ProMetic.com) is a long established biopharmaceutical company with globally recognized expertise in bioseparation, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, anemia, neutropenia, cancer and autoimmune diseases/inflammation as well as certain nephropathies. Headquartered in Laval (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and commercial activities in the U.S., Europe, Russia, Australia and Asia.
About the Person
Mr. Pierre Laurin is a senior executive with 28 years of experience in the pharmaceutical and biotechnology industry. Involved in the development of ProMetic`s platform technology since 1989, Mr. Laurin founded ProMetic Life Sciences Inc. in 1994. As Chairman until March, 2011 and President and CEO of the Corporation since its inception, he took the Corporation public on the Toronto Stock Exchange and has since raised over $450 million through equity and debt financing and multinational funding. Mr. Laurin`s corporate development achievements include the successful close of some 45 licensing agreements and joint venture agreements with multinationals including two strategic agreements with the American Red Cross. Mr. Laurin`s prior experience also includes positions with various pharmaceutical companies, including Nordic Laboratories (now Sanofi) where he played a pivotal role in the commercial success of Cardizem in Canada. Mr. Laurin holds a B.Sc. in Pharmacy and a Master degree in Pharmaceutical Sciences from the University of Montreal.
Info Source
Press Release
Short Profile